A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf
.
Virtual Ligand Screening for Structure-based Drug Design: Approaches and Progress
2007
Bioautomation
Recent progress in human genomics and proteomics has significantly increased the number of macromolecular targets potentially involved in drug discovery campaigns. Today technologies like combinatorial chemistry and high-throughput screening (HTS) authorize biological assays of a large number of small molecules against the therapeutically relevant targets. However the escalating costs highlight the need of developing novel approaches while still allowing one to explore larger chemical
doaj:ff15b8741a9e4e538ca40e68434b1c85
fatcat:ky74ryvp6razpkhwimn76hy44q